Skip to content

Retention & Reactivation Growth for Multiple Cohorts

Retention & Reactivation Growth is for a UAE clinic ready to manage several valid patient cohorts across WhatsApp and email without sending conflicting journeys to the same person. Care Journey coordinates cohort priorities, shared suppression, ownership and separate outcome tracking across the programme. The clinic gains a recurring retention system that respects the purpose and status of each relationship.

One person, three journeys, no safe next message for Retention & Reactivation Growth
One person, three journeys, no safe next message

One person, three journeys, no safe next message

A clinic's weekly calendar shows a planned-recall message, a missed-appointment follow-up and a general lifecycle email. One person appears in all three audiences. Each audience looked reasonable on its own. Together they create three competing purposes, two channels and no authoritative next state. Sending all three is not recurring management; it is an unresolved relationship-state collision.

Retention & Reactivation Growth creates the operating layer that resolves that collision before WhatsApp or email execution. Its approved public scope is recurring multi-cohort reactivation and lifecycle management across those channels. The package does not authorize an arbitrary database blast, fix a universal cadence or promise that contact will cause a booking, attendance or commercial result.

Continuity is important; volume is not the operating principle

A systematic review found that greater continuity with doctors was commonly associated with lower mortality across the included studies. (The continuity-of-care review) makes continuity a serious care context, but its mostly observational evidence does not show that a lifecycle campaign or this package produces a clinical outcome. Growth must protect the difference between supporting an appropriate relationship and manufacturing contact activity.

Reminder evidence is also narrower than a general retention claim. A Cochrane review found that mobile text reminders can improve appointment attendance compared with no reminder in the settings studied. (The reminder review) does not establish the effect of every channel, cohort, message or UAE private-clinic workflow. A UAE before-and-after study separately recorded appointments and attendance in one primary-care setting. (The UAE no-show study) provides a useful local state distinction, not a transferable target.

The portfolio is a roster of cohort contracts

Contract FieldDecision It Must SupportFailure Signal
PurposeName the single administrative relationship decision this cohort servesThe label describes a demographic list or promotion rather than a valid purpose
Admission EvidenceShow why each record currently qualifiesA past visit or silence is treated as enough
Suppression and ExclusionRemove opt-out, resolved, duplicate, unsuitable or otherwise stopped statesSuppression exists separately by channel or campaign
PrecedenceChoose what happens when the same person enters another cohortSeveral journeys can run at once without review
Owner and EscalationName who can decide, pause, route and closeAmbiguous or clinical context remains inside a marketing workflow
Exit and OutcomeSeparate response, booking, attendance, decline, unreachable, opt-out and unresolved statesA single conversion label closes incompatible outcomes

A web-analytics cohort is configured through inclusion criteria, return criteria, a metric and a calculation. (Google's cohort exploration method) is useful because it keeps entry and observed return distinct. It is not a patient-permission model. For clinic operations, every contract still needs qualified purpose, data and channel governance before an eligible state can lead to communication.

Resolve the portfolio before opening the channels

Cycle StepRequired EvidenceDecision Output
1. RefreshCurrent source fields, state age, exclusions and authorized purposeEligible, suppressed or unresolved population by cohort
2. CollideOne identity view across all active cohortsOverlap list with competing purposes exposed
3. ResolveApproved precedence, clinical or administrative escalation and ownerOne next purpose, a deliberate pause or a safe transfer
4. RouteChannel authority, reachable state and approved workflowWhatsApp, email, another authorized route or no contact
5. ObserveDelivery, response, booking and attendance recorded separatelyCohort-specific dispositions without causal overclaim
6. ReviewDenominators, unresolved collisions, exclusions, outcomes and limitationsContinue, repair, retire or rescope the cohort

Abu Dhabi's current healthcare analytics authority calls for traceable sources, formulas, transformations, assumptions and limitations and addresses privacy, access, minimization, consent, opt-out and retention. (The DoH analytics standard) is directly authoritative in its ecosystem and a prudent methodological reference elsewhere. It supports a portfolio whose denominator and state transitions can be reconstructed, while qualified review remains necessary for the clinic's jurisdiction and use.

  • Every active cohort has a named purpose and current admission evidence.
  • Suppression is shared across cohorts rather than recreated inside each campaign.
  • An identity-level collision view runs before channel scheduling.
  • A named owner can select one next purpose, pause or escalate.
  • WhatsApp and email dispositions return to the CRM without overwriting relationship truth.
  • The review preserves cohort-specific denominators and distinct downstream states.

What This Package Covers

  • Retention & Reactivation Growth covers recurring management of several agreed cohorts across appropriate WhatsApp and email lifecycle routes.
  • The first cohort or an unstable CRM base may need Retention & Reactivation Essential before the wider programme begins.
  • Permission, suppression and clinical escalation remain essential, while response, booking and revenue outcomes remain variable.

Questions that expose portfolio readiness

These questions test whether the clinic has a governed recurring portfolio rather than several independent lists. Exact cohorts, channels, cadence, creative, systems and targets remain subject to the approved scope and current qualified review.

It covers recurring multi-cohort reactivation and lifecycle activity across WhatsApp and email. The approved authority does not imply a fixed cohort count, cadence, message volume, tool set or performance outcome.

Retention & Reactivation Growth Fit Consultation

Assess Whether Multiple Cohorts Are Ready for Growth

Tell Care Journey which cohorts and channels the clinic wants to coordinate and where overlaps currently occur. We will compare Essential with Growth, identify the readiness gaps and recommend the safest useful programme path.

Back to top
Drag